THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS)

NCT05033314 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Study terminated due to slow recruitment.

Conditions

Sickle Cell Disease
Central Venous Catheter Thrombosis
Venous Thromboembolism

Interventions

DRUG: Rivaroxaban 10 MG
DRUG: Placebo

Sponsor

University Health Network, Toronto